STEPHAN DIETRICH A (President and CEO) received a stock award from NEUBASE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/16/2019ACC: 0001387131-19-005132
DirectorOfficer· President and CEO
Since Jul 2019
+5.86M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
5.86M acquired
Non-Derivative Transactions1
Common stock
Indirect
Shares
+2.55M
Price / share
—
Trade value
—
% of position
New position
7/12/2019
0.00→2.55M
Total
Net shares
+2.55M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock Indirect | 7/12/2019 | A · Award | +2.55M | — | — | New position | 0.00 | 2.55M |
| Total | +2.55M | $0.00 | ||||||
Derivative Transactions1
Stock option (right to buy)
Direct
Converts to
Common stock
3.31M shares
Shares
+3.31M
Strike price
0.001
Held after
3.31M
Exercisable
—
7/12/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock option (right to buy) Direct | Common stock3.31M shares | 7/12/2019 | A · Award | +3.31M | 0.001 | — | 3.31M |